The inflammatory hypothesis - Any progress in risk stratification and therapeutic targets?

被引：24

作者：

Blankenberg, Stefan

Yusuf, Salim

机构：

[1] McMaster Univ Hamilton Hlth Sci, Hamilton, ON L8L 2X2, Canada

[2] Johannes Gutenberg Univ Mainz, Dept Med 2, D-6500 Mainz, Germany

[3] McMaster Univ Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada

来源：

CIRCULATION | 2006年 / 114卷 / 15期

关键词：

editorials; cardiovascular diseases; inflammation; stroke;

D O I：

10.1161/CIRCULATIONAHA.106.652081

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1557 / 1560

页数：4

共 20 条

[1] Interleukin-18 and the risk of coronary heart disease in European men -: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) [J].

Blankenberg, S ;

Luc, G ;

Ducimetière, P ;

Arveiler, D ;

Ferrières, J ;

Amouyel, P ;

Evans, A ;

Cambien, F ;

Tiret, L .

CIRCULATION, 2003, 108 (20) :2453-2459

[2] Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study [J].

Blankenberg, Stefan ;

McQueen, Matthew J. ;

Smieja, Marek ;

Pogue, Janice ;

Balion, Cynthia ;

Lonn, Eva ;

Rupprecht, Hans J. ;

Bickel, Christoph ;

Tiret, Laurence ;

Cambien, Francois ;

Gerstein, Hertzel ;

Muenzel, Thomas ;

Yusuf, Salim .

CIRCULATION, 2006, 114 (03) :201-208

[3] High serum C-reactive protein level is not an independent predictor for stroke - The Rotterdam Study [J].

Bos, Michiel J. ;

Schipper, C. Maarten A. ;

Koudstaal, Peter J. ;

Witteman, Jacqueline C. M. ;

Hofman, Albert ;

Breteler, Monique M. B. .

CIRCULATION, 2006, 114 (15) :1591-1598

[4] C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease [J].

Danesh, J ;

Wheeler, JG ;

Hirschfield, GM ;

Eda, S ;

Eiriksdottir, G ;

Rumley, A ;

Lowe, GDO ;

Pepys, MB ;

Gudnason, V .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (14) :1387-1397

[5] Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution bias [J].

Emberson, JR ;

Whincup, PH ;

Morris, RW ;

Walker, M .

EUROPEAN HEART JOURNAL, 2003, 24 (19) :1719-1726

[6] Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice [J].

Hirschfield, GM ;

Gallimore, JR ;

Kahan, MC ;

Hutchinson, WL ;

Sabin, CA ;

Benson, GM ;

Dhillon, AP ;

Tennent, GA ;

Pepys, MB .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (23) :8309-8314

[7] Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level [J].

Kathiresan, S ;

Larson, MG ;

Vasan, RS ;

Guo, CY ;

Gona, P ;

Keaney, JF ;

Wilson, PWF ;

Newton-Cheh, C ;

Musone, SL ;

Camargo, AL ;

Drake, JA ;

Levy, D ;

O'Donnell, CJ ;

Hirschhorn, JN ;

Benjamin, EJ .

CIRCULATION, 2006, 113 (11) :1415-1423

[8] C-reactive protein modulates risk prediction based on the Framingham score -: Implications for future risk assessment:: Results from a large cohort study in southern Germany [J].

Koenig, W ;

Löwel, H ;

Baumert, J ;

Meisinger, C .

CIRCULATION, 2004, 109 (11) :1349-1353

[9] Justification for the use of statins in primary prevention: An intervention trial evaluating rosuvastatin (JUPITER) - Can C-reactive protein be used to target statin therapy in primary prevention? [J].

Mora, S ;

Ridker, PM .

AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (2A) :33A-41A

[10] Inflammatory markers and the risk of coronary heart disease in men and women. [J].

Pai, JK ;

Pischon, T ;

Ma, J ;

Manson, JE ;

Hankinson, SE ;

Joshipura, K ;

Curhan, GC ;

Rifai, N ;

Cannuscio, CC ;

Stampfer, MJ ;

Rimm, EB .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (25) :2599-2610

← 1 2 →